Testing a New Medication to Slow Memory Loss in Early Alzheimer's

This trial is testing whether Siponimod, a medication originally developed for multiple sclerosis, might also help slow memory loss and brain changes in people with mild Alzheimer's disease. The medication works by helping protect brain cells and reducing harmful inflammation. Researchers want to see if taking this treatment for 12 months can slow the rate of brain shrinkage that happens with Alzheimer's.

Alzheimer's disease damages the brain in multiple ways at once, so a single treatment may not be enough to stop it. This medication is being repurposed because it has properties that could address several of these damage pathways simultaneously—something researchers believe future Alzheimer's treatments will need to do.